MIHI : Summary for MEDICAL INNOV.HLDG COM USD0.000 - Yahoo Finance

U.S. Markets closed

Medical Innovation Holdings, Inc. (MIHI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.12-0.03 (-0.95%)
At close: 2:18PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close3.15
Bid0.00 x
Ask0.00 x
Day's Range3.02 - 3.15
52 Week Range0.07 - 10.00
Avg. Volume2,054
Market Cap119.87M
PE Ratio (TTM)-390.00
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire2 months ago

    MIHI Expands its Market Presence and Enters Into Letter of Intent to Acquire Health and Lifestyle Supplements Company Designed for Better Living, Healthier and Longer Life

    Medical Innovation Holdings, Inc. (MIHI) ("MIHI" or the "Company"), today announced that on January 13, 2017 it has entered into a Letter of Intent (LOI) with a Florida-based nutraceutical company (NEWCO). Under the agreement MIHI will acquire 100% of the assets of NEWCO in a cash and stock transaction valued anywhere from $2.5-$3.5 million. NEWCO will provide a proprietary product line with specialized formulations along with Trademark product names.

  • PR Newswire2 months ago

    MIHI Enters Into A $5,000,000 Placement Agent Agreement With Moody Capital Solutions Inc.

    Medical Innovation Holdings, Inc., ("MIHI" or the "Company") (MIHI), a Company that focuses on providing advanced telemedicine services to patients in rural underserved areas, today announced that it has entered into an exclusive agreement for Moody Capital Solutions, Inc., to be the Company's investment banker in connection with the Company's efforts to secure financing and to make strategic acquisitions. Arturo "Jake" Sanchez, CEO and Director, stated: "We are very pleased that Moody Capital has agreed to act as our investment banker as they have a great amount of experience in both life sciences and technology arenas.

  • PR Newswire4 months ago

    MIHI Wholly Owned Subsidiary “BKare Diagnostics, Inc.” Enters Into Marketing & Services Agreement With Vantari Genetics

    Medical Innovation Holdings, Inc. ("MIHI" or the "Company") (MIHI), today announced that its wholly owned subsidiary, "BKare Diagnostics, Inc." (BKare) has entered into a Marketing & Services Agreement with Vantari Genetics. Under the agreement BKare will provide certain marketing and other services to the Company's network of clients and Vantari will provide genetic based testing and conduct the molecular laboratory and toxicology testing services. Vantari is a nationally known molecular diagnostic services and toxicology company, and has experience with the development and delivery of molecular laboratory and toxicology testing.